Learning Objectives: 

1. To discuss the downstream effect of polypharmacy on adherence and outcome in patients with lupus. 

2. To revisit the role of calcineurin inhibitors in the treatment of lupus nephritis. 

3. To understand the dissociation between immunologic remission and remission of proteinuria in lupus nephritis.

4. To understand the role of antimalarial therapy in lupus and its underuse by non-rheumatologists.